Market Overview

This Day In Market History: Disney Buys Star Wars, Indiana Jones Franchises

Share:
This Day In Market History: Disney Buys Star Wars, Indiana Jones Franchises

Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date.

What Happened

On Oct. 30, 2012, the Walt Disney Co (NYSE: DIS) acquired Lucasfilm Ltd. along with the rights to Star Wars and Indiana Jones.

Where The Market Was 

The S&P 500 traded around 1,412, and the Dow Jones Industrial Average lingered around 13,096.

What Else Was Going On In The World

The U.S. cultural landscape had already contracted the previous day with the merging of Penguin and Random House, and the New York Stock Exchange was in its second day of a shutdown forced by Hurricane Sandy.

Disney Expands Its Empire

Disney’s $4.05-billion purchase significantly expanded the firm’s content portfolio, which already packed a punch with Marvel and Pixar.

It didn’t take long to pay off, either. Within five years, Disney raked in $4.85 billion in global box office revenue from four blockbuster Star Wars films: “The Force Awakens,” “Rogue One,” “The Last Jedi” and “Solo: A Star Wars Story.”

The franchise supplements a slate of live-action remakes, Pixar sequels and Marvel newcomers.

Last year, “Avengers: Infinity War,” “Black Panther,” “The Incredibles 2” and “Christopher Robin” blew up the box office.

Since the Lucasfilm buyout, Disney has also acquired the entertainment assets of Twenty-First Century Fox Inc (NASDAQ: FOXA), further broadening its box office reach.

Related Links:

Disney's Remake Strategy Is Working To Perfection

How The Pixar Acquisition Has Animated Disney's Box Office Sales

Posted-In: Indiana Jones Lucasfilm Star WarsEducation Top Stories General Best of Benzinga

 

Related Articles (DIS + FOXA)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings

A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of GDP Report, Fed Decision